TR200102002T2 - Ağız yoluyla verildikten sonra gliklazid'in uzun sürede salınmasını sağlayan matris tablet. - Google Patents
Ağız yoluyla verildikten sonra gliklazid'in uzun sürede salınmasını sağlayan matris tablet.Info
- Publication number
- TR200102002T2 TR200102002T2 TR2001/02002T TR200102002T TR200102002T2 TR 200102002 T2 TR200102002 T2 TR 200102002T2 TR 2001/02002 T TR2001/02002 T TR 2001/02002T TR 200102002 T TR200102002 T TR 200102002T TR 200102002 T2 TR200102002 T2 TR 200102002T2
- Authority
- TR
- Turkey
- Prior art keywords
- gliclazide
- releases
- matrix tablet
- long time
- oral administration
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Emergency Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Mevcut bulus, gliklazid'in uzun sürede salinmasini saglayan matris tablete iliskin olup, özelligi en azindan bir selüloz polimer bilesigi ile bir glikoz surubu kombinasyonunu içermesi, söz konusu kombinasyonun gliklazid'in uzun sürede salinmasinin kontrolünü saglamasi ve gliklazid çözünme kinetiginin pH degisikliklerine karsi duyarsiz olmasini saglamasidir.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9901082A FR2788981B1 (fr) | 1999-02-01 | 1999-02-01 | Comprime matriciel permettant la liberation prolongee de gliclazide apres administration par voie orale |
Publications (1)
Publication Number | Publication Date |
---|---|
TR200102002T2 true TR200102002T2 (tr) | 2002-01-21 |
Family
ID=9541429
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2001/02002T TR200102002T2 (tr) | 1999-02-01 | 1999-10-15 | Ağız yoluyla verildikten sonra gliklazid'in uzun sürede salınmasını sağlayan matris tablet. |
Country Status (37)
Country | Link |
---|---|
US (1) | US6733782B1 (tr) |
EP (1) | EP1148871B1 (tr) |
JP (2) | JP4716465B2 (tr) |
KR (1) | KR100491600B1 (tr) |
CN (1) | CN1160061C (tr) |
AP (1) | AP1243A (tr) |
AT (1) | ATE296621T1 (tr) |
AU (1) | AU764516B2 (tr) |
BR (1) | BR9917012A (tr) |
CA (1) | CA2273420C (tr) |
CZ (1) | CZ298196B6 (tr) |
DE (1) | DE69925639T2 (tr) |
DK (1) | DK1148871T3 (tr) |
EA (1) | EA002625B1 (tr) |
EE (1) | EE05024B1 (tr) |
ES (1) | ES2241323T3 (tr) |
FR (1) | FR2788981B1 (tr) |
GE (1) | GEP20053501B (tr) |
HK (1) | HK1043049A1 (tr) |
HR (1) | HRP20010632B1 (tr) |
HU (1) | HU225693B1 (tr) |
ID (1) | ID30225A (tr) |
IL (2) | IL144246A0 (tr) |
ME (1) | ME00436B (tr) |
NO (1) | NO329951B1 (tr) |
NZ (1) | NZ512878A (tr) |
OA (1) | OA11756A (tr) |
PL (1) | PL194505B1 (tr) |
PT (1) | PT1148871E (tr) |
RS (1) | RS50121B (tr) |
SA (1) | SA00210446B1 (tr) |
SK (1) | SK285209B6 (tr) |
TR (1) | TR200102002T2 (tr) |
UA (1) | UA68414C2 (tr) |
WO (1) | WO2000018373A1 (tr) |
YU (1) | YU53101A (tr) |
ZA (1) | ZA200106305B (tr) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AP1243A (en) * | 1999-02-01 | 2004-02-02 | Servier Lab | Core tablet for controlled release of gliclazide after oral administration. |
SE0200539D0 (sv) * | 2002-02-25 | 2002-02-25 | Metcon Medicin Ab | Granulation process and starch granulate |
CN100391459C (zh) * | 2003-05-26 | 2008-06-04 | 沈阳药科大学 | 甲磺酸多沙唑嗪缓释制剂 |
CN1294908C (zh) * | 2003-06-08 | 2007-01-17 | 安徽省医药科技实业公司 | 口服格列齐特缓释制剂 |
EP1741435A4 (en) * | 2004-04-29 | 2009-11-11 | Lotus Pharmaceutical Co Ltd | ORAL VAPORS WITH MODIFIED RELEASE AND METHOD OF MANUFACTURING THEM |
CN100413491C (zh) * | 2004-06-14 | 2008-08-27 | 北京德众万全药物技术开发有限公司 | 一种难溶性药物的控释制剂 |
WO2006061697A1 (en) * | 2004-12-06 | 2006-06-15 | Themis Laboratories Private Limited | Sulfonylurea compositions and a process for its preparation |
EP1946780B1 (en) * | 2005-11-11 | 2012-01-11 | Asahi Kasei Chemicals Corporation | Controlled release solid preparation |
US20080286343A1 (en) * | 2007-05-16 | 2008-11-20 | Dzenana Cengic | Solid form |
TR200704897A1 (tr) * | 2007-07-13 | 2009-02-23 | Sanovel �La� Sanay� Ve T�Caret Anon�M ��Rket� | Uzatılmış salım sağlayan gliklazid formülasyonları@ |
TR200708938A2 (tr) * | 2007-12-26 | 2008-11-21 | Ali̇ Rai̇f İlaç Sanayi̇ Ve Ti̇caret A.Ş. | Uzatılmış salım sağlayan gliklazid tablet |
ITFI20080016A1 (it) * | 2008-02-05 | 2009-08-06 | Valpharma Sa | Formulazioni farmaceutiche orali contenenti gliclazide. |
FR2928836B1 (fr) * | 2008-03-21 | 2011-08-26 | Servier Lab | Forme galenique secable permettant une liberation modifiee du principe actif |
WO2009140279A2 (en) * | 2008-05-12 | 2009-11-19 | Concert Pharmaceuticals, Inc. | Sulfonyl urea compounds |
EP2181705A1 (en) | 2008-10-31 | 2010-05-05 | Disphar International B.V. | Sustained-release formulation of gliclazide |
KR20110117216A (ko) * | 2009-03-03 | 2011-10-26 | 제노포트 인코포레이티드 | R-바클로펜 전구약물의 서방형 경구 투약 형태 |
JP5669837B2 (ja) | 2010-06-16 | 2015-02-18 | 帝人ファーマ株式会社 | 放出制御型の有核錠剤 |
EP2468268B1 (en) | 2010-12-21 | 2017-12-13 | Sanovel Ilaç Sanayi Ve Ticaret Anonim Sirketi | Combination composition of vildagliptin and gliclazide |
TR201107482A1 (tr) | 2010-12-21 | 2012-07-23 | Sanovel İlaç San.Ve Ti̇c.A.Ş. | Vildagliptin ve gliklazidin iki tabakalı kombinasyon kompozisyonu. |
TR201103946A1 (tr) | 2011-04-22 | 2012-11-21 | Sanovel İlaç Sanayi̇ Ve Ti̇caret Anoni̇m Şi̇rketi̇ | Kontrollü salım sağlayan gliklazid formülasyonları. |
JO3283B1 (ar) | 2011-04-26 | 2018-09-16 | Sanofi Sa | تركيب يتضمن أفليبيرسيبت, حمض فولينيك, 5- فلورويوراسيل (5- Fu) وإرينوسيتان (FOLFIRI) |
WO2013124832A2 (en) * | 2012-02-24 | 2013-08-29 | Ranbaxy Laboratories Limited | Stabilized controlled-release pharmaceutical composition comprising gliclazide |
EP2958548A1 (en) * | 2013-02-19 | 2015-12-30 | Sanovel Ilac Sanayi ve Ticaret A.S. | A production process for gliclazide formulations |
ITFI20130184A1 (it) * | 2013-08-01 | 2015-02-02 | Valpharma Internat S P A | Una formulazione farmaceutica di gliclazide a rilascio modificato, somministrabile per via orale, e suo metodo di produzione. |
ITMI20132065A1 (it) * | 2013-12-11 | 2015-06-12 | Farmatron Ltd | Sistemi terapeutici a rilascio modificato per la somministrazione orale di curcumina nel trattamento delle malattie intestinali |
MX2017000840A (es) | 2014-07-18 | 2017-05-04 | Sanofi Sa | Metodo para predecir el resultado de un tratamiento con aflibercept de un paciente que se sospecha que padece un cancer. |
WO2016042568A1 (en) * | 2014-09-16 | 2016-03-24 | Suresh Pareek | Extended release formulation of gliclazide |
CN111329841B (zh) * | 2020-03-04 | 2021-11-19 | 山东鲁抗医药集团赛特有限责任公司 | 格列齐特缓释片及其制备方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1449404A (en) * | 1973-03-30 | 1976-09-15 | Science Union & Cie | N-arylsulphonyl urea derivatives |
US4056623A (en) * | 1975-03-05 | 1977-11-01 | Science Union Et Cie, Societe Francaise De Recherche Medicale | Methods of treating animals suffering from hyperlipidemia using certain N-phenyl sulphonyl-N'-(3-azabicycloalkyl) ureas |
US5057321A (en) * | 1990-06-13 | 1991-10-15 | Alza Corporation | Dosage form comprising drug and maltodextrin |
IT1246188B (it) * | 1990-07-27 | 1994-11-16 | Resa Farma | Procedimento per la preparazione di composizioni farmaceutiche aventi aumentata velocita' di dissoluzione della sostanza attiva e composizioni ottenute. |
DE4336159A1 (de) * | 1993-10-22 | 1995-04-27 | Kurt Heinz Prof Dr Bauer | Hochwirksame, den Wirkstoff schnell oder kontrolliert freisetzende Zubereitungsformen von Sulfonylharnstoffen und Verfahren zu deren Herstellung |
US6056977A (en) * | 1997-10-15 | 2000-05-02 | Edward Mendell Co., Inc. | Once-a-day controlled release sulfonylurea formulation |
AP1243A (en) * | 1999-02-01 | 2004-02-02 | Servier Lab | Core tablet for controlled release of gliclazide after oral administration. |
-
1999
- 1999-01-15 AP APAP/P/2001/002212A patent/AP1243A/en active
- 1999-02-01 FR FR9901082A patent/FR2788981B1/fr not_active Expired - Fee Related
- 1999-05-27 CA CA002273420A patent/CA2273420C/fr not_active Expired - Lifetime
- 1999-10-15 PL PL99356707A patent/PL194505B1/pl unknown
- 1999-10-15 EE EEP200100398A patent/EE05024B1/xx unknown
- 1999-10-15 RS YUP-531/01A patent/RS50121B/sr unknown
- 1999-10-15 ES ES99947592T patent/ES2241323T3/es not_active Expired - Lifetime
- 1999-10-15 ME MEP-2008-663A patent/ME00436B/me unknown
- 1999-10-15 IL IL14424699A patent/IL144246A0/xx active IP Right Grant
- 1999-10-15 US US09/890,427 patent/US6733782B1/en not_active Expired - Lifetime
- 1999-10-15 AT AT99947592T patent/ATE296621T1/de active
- 1999-10-15 NZ NZ512878A patent/NZ512878A/en not_active IP Right Cessation
- 1999-10-15 SK SK1095-2001A patent/SK285209B6/sk not_active IP Right Cessation
- 1999-10-15 ID IDW00200101671A patent/ID30225A/id unknown
- 1999-10-15 TR TR2001/02002T patent/TR200102002T2/tr unknown
- 1999-10-15 YU YU53101A patent/YU53101A/sh unknown
- 1999-10-15 AU AU60982/99A patent/AU764516B2/en not_active Expired
- 1999-10-15 CN CNB998159603A patent/CN1160061C/zh not_active Expired - Lifetime
- 1999-10-15 JP JP2000571893A patent/JP4716465B2/ja not_active Expired - Lifetime
- 1999-10-15 GE GE4589A patent/GEP20053501B/en unknown
- 1999-10-15 EA EA200100827A patent/EA002625B1/ru not_active IP Right Cessation
- 1999-10-15 BR BR9917012-4A patent/BR9917012A/pt not_active Application Discontinuation
- 1999-10-15 OA OA1200100197A patent/OA11756A/en unknown
- 1999-10-15 UA UA2001086035A patent/UA68414C2/uk unknown
- 1999-10-15 WO PCT/FR1999/002520 patent/WO2000018373A1/fr active IP Right Grant
- 1999-10-15 PT PT99947592T patent/PT1148871E/pt unknown
- 1999-10-15 EP EP99947592A patent/EP1148871B1/fr not_active Expired - Lifetime
- 1999-10-15 HU HU0105365A patent/HU225693B1/hu unknown
- 1999-10-15 KR KR10-2001-7009694A patent/KR100491600B1/ko active IP Right Grant
- 1999-10-15 DK DK99947592T patent/DK1148871T3/da active
- 1999-10-15 DE DE69925639T patent/DE69925639T2/de not_active Expired - Lifetime
- 1999-10-15 CZ CZ20012661A patent/CZ298196B6/cs not_active IP Right Cessation
-
2000
- 2000-10-10 SA SA00210446A patent/SA00210446B1/ar unknown
-
2001
- 2001-07-11 IL IL144246A patent/IL144246A/en not_active IP Right Cessation
- 2001-07-31 NO NO20013757A patent/NO329951B1/no not_active IP Right Cessation
- 2001-07-31 ZA ZA200106305A patent/ZA200106305B/xx unknown
- 2001-08-30 HR HR20010632A patent/HRP20010632B1/xx not_active IP Right Cessation
-
2002
- 2002-05-31 HK HK02104094A patent/HK1043049A1/xx not_active IP Right Cessation
-
2008
- 2008-03-07 JP JP2008057532A patent/JP2008179649A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TR200102002T2 (tr) | Ağız yoluyla verildikten sonra gliklazid'in uzun sürede salınmasını sağlayan matris tablet. | |
TR200200966T1 (tr) | Tüberkülöz ilaçlarının yeni farmasötik terkipleri ve hazırlanma prosesleri | |
TR200003014T2 (tr) | Farmasötik maddelerin yavaş salınımı için bir matris olarak işlevsel gruplara sahip olan çapraz-bağlanmış yüksek amiloz nişasta | |
NO20001042D0 (no) | Oftalmiske preparater med forsinket frigivelse inneholdende vannoppløselige medikamenter | |
EA200500079A1 (ru) | Композиция таблетки прамипексола с замедленным высвобождением | |
TR199800743A2 (tr) | Ispençiyari uygulamaya mahsus devamli salivermeli polimer karisim matrisi. | |
KR950702409A (ko) | 방출 조절 모르핀 제제(controlled release morphine preparation) | |
BR9913553A (pt) | Formulação de ranolazina de liberação sustentada | |
DE69622510D1 (de) | Nifedipinzubereitung mit langanhaltender Freisetzung | |
ATE232091T1 (de) | Orale pharmazeutische zusammensetzungen mit verzögerter freisetzung von reversiblen protonpumpen-inhibitoren | |
TR200201685T1 (tr) | Hızlı başlangıçlı formülasyon. | |
DK0810857T3 (da) | Colon-lægemiddelafgivelsessammensætning | |
TWI235068B (en) | Sustained-release pharmaceutical composition | |
TR199902608T2 (tr) | Bogaz yumusatici bilesimler. | |
DE3482374D1 (de) | Pharmazeutische zusammensetzung mit verzoegerter abgabe. | |
CY1108587T1 (el) | Φαρμακευτικη συνθεση για τροποποιημενη απελευθερωση ενος ευαισθητοποιητη ινσουλινης και μετφορμινης | |
NO20005394L (no) | Legemiddelavleveringssammensetninger bestående av klebende mikrosfærer | |
DE60038536D1 (de) | Matrixsystem mit verzögerter freisetzung für hochlösliche wirkstoffe | |
DE60023107D1 (de) | Zubereitungen mit verbesserter kontrollierter freisetzung | |
PT1318792E (pt) | Composicao de libertacao prolongada que contem claritromicina | |
EA200001201A2 (ru) | Таблетка с основой, позволяющая осуществлять пролонгированное высвобождение триметазидина после введения оральным путем | |
TR200402419T4 (tr) | Okskarbazepin içeren süspansiyon. | |
DE69706748D1 (de) | Oral anzuwendende Matrixtabletten mit verzögerter Wirkstoffabgabe enthaltend Tianeptin Natriumsalz | |
TR200503846T2 (tr) | Değiştirilmiş salimli ensülin sensitizörü için fterkip ve kullanımı | |
NZ234211A (en) | Recompressed sustained release oral pharmaceutical composition containing water sensitive pharmaceutical agents, cellulose polymer and a lubricant |